| The interferon landscape along the respiratory tract impacts the severity of COVID-19 B Sposito, A Broggi, L Pandolfi, S Crotta, N Clementi, R Ferrarese, S Sisti, ... Cell 184 (19), 4953-4968. e16, 2021 | 233 | 2021 |
| The initial interplay between HIV and mucosal innate immunity V Caputo, M Libera, S Sisti, B Giuliani, RA Diotti, E Criscuolo Frontiers in Immunology 14, 1104423, 2023 | 17 | 2023 |
| Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients. B Sposito, A Broggi, L Pandolfi, S Crotta, R Ferrarese, S Sisti, N Clementi, ... BioRxiv, 2021 | 14 | 2021 |
| ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota T Eberhart, FU Stanley, L Ricci, T Chirico, R Ferrarese, S Sisti, A Scagliola, ... Cell Death & Disease 15 (2), 105, 2024 | 3 | 2024 |
| Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through next-generation sequencing (NGS) based approaches S Sisti, RA Diotti, V Caputo, M Libera, R Ferrarese, S Carletti, P Rizzi, ... New Microbiol 45 (3), 199-209, 2022 | 3 | 2022 |
| A high-fiber dietary intervention (NUTRIVENTION) in precursor plasma cell disorders improves disease biomarkers and delays progression to myeloma U Shah, LL Cogrossi, A Derkach, F Castro, T Fei, S DeWolf, JJ Garces, ... | 1 | 2024 |
| Single spike mutation differentiating XBB. 1 and XBB. 1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement E Criscuolo, B Giuliani, M Castelli, M Cavallaro, S Sisti, R Burioni, ... Frontiers in Immunology 15, 1501200, 2024 | | 2024 |
| A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Biomarkers of Disease and May Delay Progression to Myeloma UA Shah, LL Cogrossi, A Derkach, F Castro, T Fei, S DeWolf, JJ Garces, ... Blood 144 (Supplement 1), 671-671, 2024 | | 2024 |
| 602 High fiber dietary intervention in plasma cell disorders improves microbiome and immune biomarkers and delays progression to myeloma UA Shah, LL Cogrossi, A Derkach, F Castro, T Fei, S DeWolf, J Garces, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Microbiome Modulation Uncouples Efficacy and Toxicity Induced by Programmed Death-1/Programmed Death-Ligand1 Blockade LL Cogrossi, P Zordan, M Grioni, A Tosi, N Rizzo, A Policastro, B Mattorre, ... bioRxiv, 2024.05. 08.590282, 2024 | | 2024 |
| Exploiting the Gut Microbiota to Boost Immunotherapy and Switch the Trajectory of Multiple Myeloma LL Cogrossi, M Grioni, P Zordan, B Mattorre, M Lorenzoni, G Meregalli, ... Blood 142, 754, 2023 | | 2023 |
| P-384 Exploiting fiber-rich diet to perturb the microbiota-immune axis and thwart multiple myeloma progression LL Cogrossi, A Policastro, M Grion, S Sisti, M Chesi, L Bergsagel, ... Clinical Lymphoma Myeloma and Leukemia 23, S252, 2023 | | 2023 |
| OA-01 Exploiting microbiota commensals to potentiate immunotherapy and delay multiple myeloma evolution LL Cogrossi, R Ferrarese, M Grioni, P Zordan, B Mattorre, M Lorenzoni, ... Clinical Lymphoma Myeloma and Leukemia 23, S1, 2023 | | 2023 |
| Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients.(preprint) A Broggi, L Pandolfi, S Crotta, R Ferrarese, S Sisti, N Clementi, A Ambrosi, ... | | 2021 |
